The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 12 of the 16 sources its claims cite were checked for support.
Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes
Open accessAbstract
BACKGROUND: To describe longitudinal prevalence and risk factors associated with cardiovascular autonomic neuropathy (CAN), defined by heart rate variability (HRV) indices, and evaluate the impact of CAN on cardiovascular disease (CVD), in adults with type 1 diabetes (T1D) from the Epidemiology of Diabetes Interventions and Complications (EDIC) study. METHODS: Standard resting electrocardiogram (ECG) recordings were obtained annually in 997 participants (mean ± SD age 56.2 ± 6.8 years; T1D duration 34.7 ± 7.9 years; 48% female) between 2015 and 2022. The standard deviation of normally conducted R-R intervals (SDNN) and root mean square of successive differences between normal-to-normal R-R intervals (rMSSD) were used to define CAN using previously validated cut-offs in this cohort from gold-standard cardiovascular reflex tests (CARTs). Generalized estimating equation models were used to evaluate the association of ECG-derived CAN with individual risk factors over repeated time points. Kaplan-Meier estimates were used to describe the cumulative incidence of the first occurrence of any-CVD and of MACE by ECG-derived CAN status, and Cox proportional hazards regression models were used to estimate the effect of ECG-derived CAN adjusted for age and HbA1c. RESULTS: The prevalence of ECG-derived CAN (~ 64%) was stable. Higher pulse rate (OR [95% CI] 1.08 [1.07,1.10] per 1 bpm) and HbA1c (1.43 [1.29,1.58] per 1%) were the most significant risk factors for CAN, followed by older age, male sex, higher albumin excretion rate, and hypertension history. The cumulative incidence of first occurrence of any-CVD over 7 years of follow-up was significantly higher in participants with vs. without CAN (HR [95% CI] any-CVD 2.37 [1.43,3.94]), which remained significant adjusting for mean HbA1c and age, but was attenuated with further adjustment for other factors. CONCLUSIONS: The prevalence of and risk factors for standard resting ECG-derived CAN were similar to previously reported estimates from CARTs. CVD risk was significantly higher in those with vs. without CAN. These data support future studies examining the diagnostic utility of HRV indices at the point of care for risk stratification. TRIAL REGISTRATION: clinicaltrials.gov NCT00360815 and NCT00360893.
Overview
CoChat Summary
TL;DR
In 997 adults with type 1 diabetes in DCCT/EDIC, ECG-derived cardiovascular autonomic neuropathy (CAN) prevalence was stable at ~64% from 2015–2022. ECG-derived CAN was associated with higher risk of any-CVD and MACE over 7 years, though associations attenuated after adjustment for other risk factors.
Key findings
- The average prevalence of ECG-derived CAN over the 7-year follow-up was 64% (62% intensive vs. 67% conventional, p = 0.0359), and median SDNN/rMSSD values and CAN prevalence were stable between EDIC years 22 and 29.
- In the final multivariable GEE model, higher mean pulse rate (OR 1.08 [1.07, 1.10] per 1 bpm) and higher mean HbA1c (OR 1.43 [1.29, 1.58] per 1%) were the most significant risk factors for ECG-derived CAN, followed by older age (OR 1.21 per 5 years), male sex (OR 1.39), higher AER (OR 1.02 per 20% increase), and history of hypertension (OR 1.46).
- Among participants free of CVD at EDIC year 22 (n = 873 for any-CVD; n = 947 for MACE), there were 88 incident any-CVD cases and 50 incident MACE cases over 7 years. Cumulative incidence was higher with vs. without ECG-derived CAN: unadjusted HR any-CVD 2.37 [1.43, 3.94] and MACE 3.33 [1.56, 7.10]; age- and HbA1c-adjusted HR any-CVD 1.71 [1.01, 2.90] and MACE 2.17 [1.00, 4.73].
- In time-dependent Cox models, ECG-derived CAN was associated with any-CVD and MACE unadjusted (any-CVD 2.52 [1.46, 4.33]; MACE 3.33 [1.50, 7.41]) and after age/HbA1c adjustment (any-CVD 1.95 [1.12, 3.38]; MACE 2.32 [1.03, 5.25]), but was attenuated with further adjustment for other risk factors (any-CVD 1.69 [0.97, 2.95], p = 0.0663; MACE 2.21 [0.98, 5.00], p = 0.0568).
Methods
- Longitudinal cohort study within DCCT/EDIC: 997 participants with type 1 diabetes and ECG-derived CAN data at EDIC year 22 (2015), followed through EDIC year 29 (2022); mean ± SD age 56.2 ± 6.8 years, type 1 diabetes duration 34.7 ± 7.9 years, 48% female.
- Annual standard 10-second, 12-lead resting ECGs were centrally processed; SDNN and rMSSD were derived, and ECG-derived CAN was defined as SDNN < 17.13 and rMSSD < 24.94 ms based on prior validation against gold-standard cardiovascular autonomic reflex tests (CARTs).
- Generalized estimating equation models evaluated risk factors over repeated time points; Kaplan-Meier estimates described cumulative incidence of first any-CVD and MACE; Cox proportional hazards models estimated the effect of ECG-derived CAN unadjusted and adjusted for age and HbA1c, including CAN as a time-dependent covariate in final multivariable models.
Limitations
- Stated: the cohort was predominantly non-Hispanic White with type 1 diabetes, limiting generalizability to other type 1 diabetes populations; digital ECG data were not available before 2015.
- Stated: analyses were exploratory and not adjusted for multiple testing.
- Evident from the text: the observational design cannot establish causality, and the association between ECG-derived CAN and CVD/MACE attenuated after adjustment for other previously identified risk factors, leaving the independent effect uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
6 Valid · 0 Not valid · 0 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our group has previously demonstrated in the large, well-characterized DCCT/EDIC study cohort that indices of heart rate variability (HRV) obtained from standard electrocardiograms (ECGs) are valid surrogate measures of CAN in T1D [13].”
- Also stated in: § Conclusions · boosted
“These data demonstrate the validity of ECG-derived indices of HRV as surrogate measures of CAN.”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Background
What the sources say
- Partly supportedcites [13] Pop-Busui R, Backlund JC, Bebu I et al. 2021 utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients. J Diabetes Investig. https://doi.org/10.1111/jdi.13635 sourceExperimental — accuracy not yet measured
The Results report fair performance and agreement between ECG-derived HRV indices and gold-standard cardiovascular reflex tests in the DCCT/EDIC type 1 diabetes cohort. The Discussion says these findings provide “some support” for their use as a CAN measure and cautions that sensitivity and specificity might not be ideal. Calling the indices valid surrogate measures without that qualification overstates the paper’s conclusion. (LLM, conf=0.87)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Conclusions · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Participants originally enrolled in the DCCT intensive vs. conventional therapy group had significantly higher SDNN and rMSSD values over time (p = 0.0062 and p = 0.0031, respectively) (Supplementary Fig. 1).”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > Prevalence and risk factors for ECG-derived CAN
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The cumulative incidence of the first occurrence of any-CVD and of MACE (Fig. 2) was significantly higher in participants with vs. without ECG-derived CAN at EDIC year 22 (HR [95% CI] any-CVD 2.37 [1.43,3.94]; MACE 3.33 [1.56,7.10]).”
- Also stated in: § ECG-derived CAN as a predictor of CVD · plain
“ECG-derived CAN (yes vs. no) | 3.33 (1.50,7.41) | 8.72 | 0.0032”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > ECG-derived CAN as a predictor of CVD
plainstates an associationn = 50 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § ECG-derived CAN as a predictor of CVD · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These associations remained significant after adjustment for EDIC year 22 HbA1c and age (any-CVD 1.71 [1.01,2.90]; MACE 2.17 [1.00,4.73]).”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > ECG-derived CAN as a predictor of CVD
plainstates an associationn = 88 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“followed by higher mean HbA1c (1.43 [1.29,1.58] per 1%), older age, male sex, higher AER, and history of hypertension (Table 2).”
- Also stated in: § Final multivariable model · plain
“Age (per 5 years) | 1.21 (1.13, 1.29) | 5.72 | < 0.0001”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > Final multivariable model
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Final multivariable model · plain
18 more claims
Create a free account to see all 30 claims and to verify the 2 references still open.
- Probably not a substantial claim. 3
- It may state two separate claims as one. 4
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > ECG-derived CAN as a predictor of CVD
“the unadjusted (any-CVD 2.52 [1.46,4.33]; MACE 3.33 [1.50,7.41])”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > ECG-derived CAN as a predictor of CVD
“| ECG-derived CAN (yes vs. no) | 2.37 (1.43,3.94) | 11.1 | 0.0009 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Methods > Statistical analyses
“Candidate risk factors were grouped into 10 blocks as previously described: design, physical, behavioral, blood pressure, medications, lipids, diabetes-related kidney disease, hypoglycemia, and glycemia [5].”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Methods > Statistical analyses
“design, physical, behavioral, blood pressure, medications, lipids, diabetes-related kidney disease, hypoglycemia, and glycemia”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Discussion
“ECG-derived CAN and CVD during the 7-year follow-up (HR [95% CI] 2.6 [1.5,4.5])”
§ Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes > Results > ECG-derived CAN as a predictor of CVD
“the unadjusted (any-CVD 2.52 [1.46,4.33]; MACE 3.33 [1.50,7.41])”
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“LDL cholesterol was calculated using the Friedewald equation [18].”
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · cited 1×
“Estimated glomerular filtration rates (eGFR) were calculated from serum creatinine measured annually using the Chronic Kidney Disease Epidemiology Collaboration equation [20].”
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 2×
“Yet, despite the proven prognostic value and current guideline recommendations for screening [11, 12].”
Self-citationSpallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957 · cited 1×
“However, despite the reductions in CAN risk resulting from intensive diabetes management in both T1D and type 2 diabetes (T2D) [6], the prevalence of CAN remains high, affecting nearly 40% of those with long-duration T1D and 60% of those with longstanding T2D [5, 7].”
Self-citation
Cited by
Marzoog, B. A. (2025) · medRxiv · doi:10.1101/2025.11.01.25339311 · Cited by 1
“…body of literature documenting the impact of diabetes on cardiac electrophysiology, including autonomic neuropathy, fibrosis, and metabolic changes that affect action potential duration and conduction velocity, manifesting as changes in parameters like QTc and heart rate variability [19–21].”
Yang, S., Zhou, H., Wu, H., Ma, G., & Chen, J. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.110095
Jia, B., Jiang, Z., Wen, X., Yang, M., & Wang, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1831010
Yang, T., Fang, D., Wu, T., Sun, C., Cong, X., Gao, L., Ma, H., Ge, Z., Gu, T., & Bi, Y. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag312
Type 1 diabetes and cardiovascular medicine
Jenkins, A. J., Huang, M., Hemphill, M., Chen, D., Ha, J. T., Sata, Y., Sindone, A. P., Gnanenthiran, S. R., & Lan, N. S. R. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00338-9
“In EDIC, CAN conferred approximately 2-fold higher risk of incident CVD independent of glycaemia and age [134], consistent with earlier reports of a 2-3-fold excess in cardiovascular and all-cause mortality [137].”
Influential
Metadata
- Authors
- Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., Vella, A., Perkins, B. A., Bebu, I., Pop-Busui, R., & for the DCCT/EDIC Research Group
- Affiliations
- George Washington University (US)
- University of Michigan (US)
- Washington University in St. Louis (US)
- University of Washington (US)
- University of Minnesota (US)
- HealthPartners (US)
- National Institutes of Health (US)
- Wake Forest University Health Sciences (US)
- Mayo Clinic (US)
- University of Toronto (CA)
- Corresponding author
- Braffett, Barbara H.
- ORCID
- Venue
- Cardiovascular Diabetology
- Published
- 2025-08-13
- Volume
- 24
- Issue
- 1
- Pages
- 334-334
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC12351983
- OpenAlex
- W4413116290
- Semantic Scholar
- 2979abfb112ecdb3e49e46375af5fbd7ac11eb23
- Cited by
- 5
- References
- 34
- Citations by year
- 2026: 4 · 2025: 1
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK094176, U01 DK094157)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- cardiac autonomic neuropathy, heart rate variability, type 1 diabetes, cardiovascular disease, major adverse cardiovascular events, risk factors, pulse rate, HbA1c, urinary albumin excretion rate, hypertension, prevalence, cardiovascular reflex tests, cardiovascular risk stratification, diabetes complications
- MeSH terms
- Heart Disease Risk Factors, Adult, Aged, Autonomic Nervous System, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Electrocardiography, Female, Heart, Heart Rate, Humans, Longitudinal Studies, Male, Middle Aged, Prognosis, Time Factors, United States, Incidence, Prevalence, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. https://app.cochat.ai/papers/10.1186/s12933-025-02856-9
- The paper
- Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., Vella, A., Perkins, B. A., Bebu, I., Pop-Busui, R., & for the DCCT/EDIC Research Group. (2025). Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-025-02856-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

